Chronic complications of hypoglycemia and hyperglycemia

From WikiLectures

This article doesn't meet WikiLectures quality standards.
This article doesn't meet WikiLectures quality standards.

This article seems to not fulfill most of the items on our Editorial Process checklist.

As such, it's going to be deleted soon.

To the author of this article: if you still work on this article, make sure to replace this template with the Under construction template. However, be aware that if you don't make any changes to the article after that soon enough, the article will still be deleted.

To find out what you need to do to improve this article, read Help:Editorial process. Feel free to ask for help on Forum:Support.

To see how articles on WikiLectures should look like, check out articles in Category:Finished articles.

For more information, contact the user who inserted this template, you can find them in the Page History (under the "Actions" button).

Last user who modified this page: ShadyMedic


Introduction

Chronic abnormalities in glucose regulation can lead to long-term complications affecting multiple organ systems. Hyperglycemia is the primary driver of chronic diabetic complications, while recurrent hypoglycemia is especially problematic in patients treated with insulin or sulfonylureas. Both conditions negatively impact quality of life and may cause permanent damage if not properly managed.


Chronic Complications of Hypoglycemia

Recurrent or unrecognized hypoglycemia occurs mostly in insulin-treated patients, especially those with type 1 diabetes. Chronic hypoglycemia does not directly damage organs, but it leads to dangerous functional impairments.

Hypoglycemia Unawareness

Frequent episodes of hypoglycemia reduce the autonomic warning response, so the patient does not perceive early symptoms. This increases the risk of severe hypoglycemia, seizures, and coma.

Impaired Counterregulation

Repeated hypoglycemia blunts glucagon and adrenaline release. As a result:

  • The patient cannot correct hypoglycemia quickly
  • Risk of prolonged or severe episodes increases

Cognitive and Psychological Effects

  • Reduced attention, memory, or concentration
  • Fear of hypoglycemia
  • Avoidance of tight glycemic control

Impact on Daily Functioning

Patients may restrict driving, work activities, and physical exercise due to unpredictability of episodes.


Chronic Complications of Hyperglycemia

Long-term hyperglycemia leads to structural and functional damage of blood vessels and tissues. These complications are divided into microvascular and macrovascular.

Microvascular Complications

Diabetic Retinopathy

Chronic hyperglycemia causes retinal vessel damage, microaneurysms, hemorrhages, neovascularization, and potential visual loss.

Diabetic Nephropathy

Glomerular injury leads to:

  • Microalbuminuria → proteinuria
  • Declining renal function
  • Hypertension
  • Risk of chronic kidney disease or renal failure

Diabetic Neuropathy

Long-standing hyperglycemia damages peripheral nerves, leading to:

  • Sensory loss
  • Burning pain
  • Autonomic dysfunction (gastroparesis, orthostatic hypotension)
  • Foot ulcers due to loss of protective sensation

Macrovascular Complications

Coronary Artery Disease

Increased risk of myocardial infarction and heart failure.

Cerebrovascular Disease

Higher risk of ischemic stroke and transient ischemic attacks.

Peripheral Arterial Disease

Leads to claudication, poor wound healing, gangrene, and increased risk of limb amputation, especially when combined with neuropathy.

Other Long-Term Effects of Hyperglycemia

Diabetic Foot

Results from neuropathy, poor perfusion, and impaired immunity, leading to chronic wounds and infections.

Impaired Immune Function

Hyperglycemia weakens neutrophil function and increases susceptibility to infections.

Skin and Connective Tissue Changes

Includes limited joint mobility, dermopathy, and fungal infections.

Pathophysiology Summary

Chronic hyperglycemia causes tissue damage through several mechanisms:

  • Formation of advanced glycation end-products (AGEs)
  • Oxidative stress
  • Activation of protein kinase C
  • Increased polyol pathway activity

These contribute to vascular injury and organ dysfunction.

Conclusion

Chronic hypoglycemia leads mainly to impaired awareness, defective counterregulatory responses, and reduced quality of life. Chronic hyperglycemia, in contrast, causes progressive microvascular and macrovascular complications, including retinopathy, nephropathy, neuropathy, and cardiovascular disease. Good long-term glycemic control is essential to prevent or delay these outcomes.

References

  • American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care.
  • Guyton & Hall. Textbook of Medical Physiology.
  • Powers AC. Diabetes mellitus. In: Harrison’s Principles of Internal Medicine.
  • Cryer PE. Hypoglycemia in diabetes. Diabetes.
  • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control and complications. Lancet.